Delivery Order SPE2DE24DA017-SPE2D625F34YT

Award Date 1/21/25
Potential Completion Date 1/24/25
Potential Value $1.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award with ID SPE2DE24DA017|SPE2D625F884H was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $7,573.50 fixed-price delivery order is for the ACP MAX PRP SYSTEM (W/ ACDA), which is not designated as a set-aside contract. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, provides a wide range of advanced orthopedic technologies, surgical...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $1,584.00, is a Fixed Price Delivery Order with Economic Price Adjustment for the purchase of the ACP MAX PRP SYSTEM (OUS/EU). This award is not associated with a set-aside program. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has a...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $7,573.50 fixed-price delivery order is for the 4566485933 ACP MAX PRP SYSTEM (W/ ACDA), with a period of performance ending on November 22, 2024. Arthrex, a for-profit Subchapter S Corporation, has a robust portfolio of orthopedic medical products, including surgical implants, arthroscopic...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $3,633.30, is a Delivery Order for an "ACP MAX PRP SYSTEM (W/ ACDA)" and has a fixed price with economic price adjustment pricing type. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 9, 2025. The contract was not designated as a...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $3,960.00 fixed-price delivery order with economic price adjustment is for the ACP MAX PRP (Platelet-Rich Plasma) System for use overseas and in the European Union. This order falls under Arthrex's larger $471,048,172.66 Indefinite Delivery Contract (IDC) with the DLA, which enables VA medical centers...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $1,650.00 fixed-price with economic price adjustment delivery order is for the Arthrex ACP Double Syringe System, a specialized medical device used for orthopedic procedures. The contract has an ultimate completion date of December 27, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in...
This federal contract award was issued by the Department of Defense's Medical Supply Chain (DLA Troop Support) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $3,960.00, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, identified as SPE2DE24D0020, valued at $471,048,172.66 and running from June 2024 to September 2029. Under this IDC, Arthrex provides a wide range of orthopedic...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $1,926.00, is a fixed-price with economic price adjustment delivery order for the supply of 4566131520 ACP KIT SERIES I. Arthrex, a for-profit Subchapter S Corporation, has a significant single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, identified as...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $18,961.99, is for the delivery of Arthrex's ACP Double Syringe System, a specialized medical device used in orthopedic procedures. This is a Fixed Price with Economic Price Adjustment contract with a completion date of December 16, 2024. The contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of an Arthrex ACP Double Syringe System, a specialized medical device used in orthopedic procedures. The contract has a fixed price with economic price adjustment, a ceiling value of $3,300.00, and runs through November 15, 2024. This order is part of a larger Indefinite Delivery...
  • SPE2DE24DA017
    Indefinite Delivery Contract
  • SPE2DE24DA017-SPE2D625F34YT
    Delivery Order

This federal contract award, identified as SPE2DE24DA017|SPE2D625F34YT, was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The $1,127.94 fixed-price with economic price adjustment delivery order contract is for the procurement of the ACP MAX PRP SYSTEM (W/ ACDA), a specialized orthopedic medical product. Arthrex, a for-profit Subchapter S Corporation, has demonstrated extensive capabilities in providing innovative orthopedic solutions to government healthcare systems, particularly the Department of Veterans Affairs (VA) and the Department of Defense (DoD). The company holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, valued at $471,048,172.66, which allows VA medical centers nationwide to acquire Arthrex's orthopedic technologies through task orders. This latest contract award does not have a set-aside designation, indicating Arthrex's strong competitive position in the federal marketplace.

Generated 4/27/25, 12:47 AM